Coronary Intervention & Surgery

Three-year results from the BIO-RESORT trial revealed that despite significant differences in stent backbone and polymer coating, the ultrathin sirolimus-eluting stent, very-thin everolimus-eluting stent and thin-strut zotarolimus-eluting stent remained equally safe and effective through follow-up.

Complete revascularization is superior to culprit-lesion-only PCI in patients with both STEMI and multivessel disease, according to results from the COMPLETE trial, published Sept. 1 in the New England Journal of Medicine.

Using donor hearts from patients who died of traumatic brain injury might be a more viable option for transplant candidates than previously thought, according to an analysis published in the Journal of the American Heart Association Aug. 30.

Oregon Health & Science University will resume its heart transplant services this month after nearly a year of inactivity, the university announced Aug. 26.

KentuckyOne Health is nixing its month-old plan to inactivate its heart transplant program at Jewish Hospital in Louisville, instead opting to work with the University of Louisville to keep the program alive.

A single dose of the lipid-lowerer simvastatin, delivered to an organ donor pre-heart transplant, could decrease postoperative troponin levels in transplant recipients and protect the donor heart against perioperative myocardial ischemic damage.

Pig hearts injected with microRNA-199 could be suitable for human transplants within three years, according to an international group of researchers.

The FDA has expanded its indication for TAVR to low-risk patients, the agency announced August 16, approving a handful of valves for an intervention that was previously limited to intermediate- and high-risk patients.

Compared to on-pump CABG, off-pump surgery is associated with lower rates of revascularization and a significantly increased risk of all-cause death at three years, according to an analysis of the EXCEL trial.

The results of a Journal of Cardiovascular Nursing study suggest motivation is the key driver of adherence to secondary prevention measures among women who have CHD and have undergone PCI.

Patients with critical limb ischemia might be better off if they opt for endovascular-first treatment over an open surgical bypass, a Circulation: Cardiovascular Quality and Outcomes study suggests.

Surgery doesn’t improve survival in patients with isolated severe tricuspid regurgitation, researchers have found.